zofenopril has been researched along with Carotid Stenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allagnat, F; Corpataux, JM; Déglise, S; Deslarzes-Dubuis, C; Lambelet, M; Longchamp, A; Macabrey, D; Ozaki, CK | 1 |
| Bruzzese, G; Cacciatore, F; Crimi, E; de Nigris, F; Fiorito, C; Ignarro, LJ; Libardi, S; Liguori, A; Mancini, FP; Napoli, C; Sommese, L; Williams-Ignarro, S | 1 |
1 trial(s) available for zofenopril and Carotid Stenosis
| Article | Year |
|---|---|
Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Carotid Arteries; Carotid Stenosis; Dinoprost; Enalapril; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Tunica Intima; Tunica Media; Ultrasonography | 2008 |
1 other study(ies) available for zofenopril and Carotid Stenosis
| Article | Year |
|---|---|
Hydrogen Sulphide Release via the Angiotensin Converting Enzyme Inhibitor Zofenopril Prevents Intimal Hyperplasia in Human Vein Segments and in a Mouse Model of Carotid Artery Stenosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Carotid Arteries; Carotid Stenosis; Cells, Cultured; Disease Models, Animal; Humans; Hydrogen Sulfide; Hyperplasia; Hypertension; Male; Mice; Myocytes, Smooth Muscle; Organ Culture Techniques; Primary Cell Culture; Tunica Intima; Veins | 2022 |